Barclays Increases HealthStream (NASDAQ:HSTM) Price Target to $34.00

HealthStream (NASDAQ:HSTM) had its target price increased by Barclays from $32.00 to $34.00 in a research note published on Wednesday, Benzinga reports. Barclays currently has an overweight rating on the technology company’s stock.

Several other brokerages have also recently issued reports on HSTM. Canaccord Genuity Group raised their price objective on HealthStream from $27.00 to $28.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. Craig Hallum upgraded HealthStream to a “strong-buy” rating in a research note on Thursday, October 17th. Finally, StockNews.com cut HealthStream from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.50.

HealthStream Price Performance

Shares of HSTM opened at $28.31 on Wednesday. The business’s fifty day moving average price is $28.72 and its 200 day moving average price is $27.92. HealthStream has a 12-month low of $23.92 and a 12-month high of $31.15. The stock has a market capitalization of $860.91 million, a PE ratio of 43.55, a price-to-earnings-growth ratio of 4.45 and a beta of 0.36.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.06. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. The firm had revenue of $73.10 million for the quarter, compared to analysts’ expectations of $73.53 million. During the same period last year, the business posted $0.13 earnings per share. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. As a group, research analysts anticipate that HealthStream will post 0.56 earnings per share for the current fiscal year.

HealthStream Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be issued a $0.028 dividend. This represents a $0.11 annualized dividend and a yield of 0.40%. The ex-dividend date is Monday, November 4th. HealthStream’s payout ratio is currently 16.92%.

Insider Buying and Selling

In related news, SVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now owns 9,527 shares of the company’s stock, valued at $267,041.81. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now owns 22,326 shares of the company’s stock, valued at $636,960.78. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Kevin P. O’hara sold 3,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the completion of the sale, the senior vice president now owns 9,527 shares in the company, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 20.60% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Hedge funds and other institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC raised its position in HealthStream by 172.1% in the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company’s stock worth $28,000 after acquiring an additional 630 shares in the last quarter. Point72 DIFC Ltd bought a new stake in HealthStream in the second quarter worth about $38,000. Copeland Capital Management LLC bought a new stake in HealthStream in the third quarter worth about $63,000. CWM LLC raised its position in HealthStream by 405.4% in the second quarter. CWM LLC now owns 2,709 shares of the technology company’s stock worth $76,000 after acquiring an additional 2,173 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in HealthStream in the second quarter worth about $214,000. 69.58% of the stock is currently owned by institutional investors.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.